Parkman Healthcare Partners LLC Dexcom Inc Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

A detailed history of Parkman Healthcare Partners LLC transactions in Dexcom Inc stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 70,588 shares of DXCM stock, worth $5.66 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares

70,588

Previous 156,855 55.0%

Holding current value

$5.66 Million

Previous $17.8 Million 73.4%

% of portfolio

0.67%

Previous 2.62%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$64.0 - $116.06 $5.52 Million - $10 Million	-86,267 Reduced 55.0%	70,588 $4.73 Million
Q2 2024 Aug 14, 2024	SELL	$110.31 - $140.45 $1.63 Million - $2.08 Million	-14,810 Reduced 8.63%	156,855 $17.8 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $6.16 Million - $7.56 Million	-53,950 Reduced 23.91%	171,665 $23.8 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $3.01 Million - $4.95 Million	-39,903 Reduced 15.03%	225,615 $28 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $15.5 Million - $24.9 Million	180,392 Added 211.91%	265,518 $24.8 Million
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $697,201 - $811,945	6,199 Added 7.85%	85,126 $10.9 Million
Q1 2023 May 12, 2023	BUY	$104.0 - $122.92 $1.68 Million - $1.99 Million	16,197 Added 25.82%	78,927 $9.17 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $1.9 Million - $2.74 Million	22,372 Added 55.43%	62,730 $7.1 Million
Q3 2022 Nov 14, 2022	BUY	$76.35 - $94.18 $421,757 - $520,250	5,524 Added 15.86%	40,358 $3.25 Million
Q2 2022 Aug 12, 2022	BUY	$67.99 - $132.89 $1.5 Million - $2.94 Million	22,097 Added 173.49%	34,834 $2.6 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $1.9 Million - $2.63 Million	-20,169 Reduced 61.29%	12,737 $6.52 Million
Q4 2021 Feb 11, 2022	SELL	$129.87 - $162.82 $1.63 Million - $2.04 Million	-12,552 Reduced 27.61%	32,906 $17.7 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $533,550 - $715,900	-5,000 Reduced 9.91%	45,458 $24.9 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $1.03 Million - $1.38 Million	12,740 Added 33.78%	50,458 $21.5 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $323,049 - $399,059	-3,810 Reduced 9.17%	37,718 $13.6 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $932,802 - $1.25 Million	11,959 Added 40.44%	41,528 $15.4 Million
Q3 2020 Nov 13, 2020	SELL	$95.51 - $112.95 $285,670 - $337,833	-2,991 Reduced 9.19%	29,569 $12.2 Million
Q2 2020 Aug 13, 2020	BUY	$62.68 - $105.34 $33,032 - $55,514	527 Added 1.65%	32,560 $13.2 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $141,792 - $224,394	-2,967 Reduced 8.48%	32,033 $8.63 Million
Q4 2019 Feb 13, 2020	BUY	$36.62 - $57.29 $1.28 Million - $2.01 Million	35,000 New	35,000 $7.66 Million

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account

Parkman Healthcare Partners LLC Dexcom Inc Transaction History